# Veliflapon (DG-031)to Prevent Heart Attacks or Stroke in Patients With a History of Heart Attack or Unstable Angina

> **NCT00353067** · PHASE3 · SUSPENDED · sponsor: **deCODE genetics** · enrollment: 3450 (—)

## Conditions studied

- Acute Coronary Syndrome

## Interventions

- **DRUG:** veliflapon (DG-031)

## Key facts

- **NCT ID:** NCT00353067
- **Lead sponsor:** deCODE genetics
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** SUSPENDED
- **Start date:** 2006-05
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** 3450 (—)
- **Last updated:** 2006-11-29

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00353067

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00353067, "Veliflapon (DG-031)to Prevent Heart Attacks or Stroke in Patients With a History of Heart Attack or Unstable Angina". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00353067. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*